Hikma Pharmaceuticals USA Inc. has successfully won approval for a supplementary new drug application to manufacture and market bucinoroxine hydrochlo...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
CVS Pharmacy announced the approval of ANDA090685 for PURELAX (polyethylene glycol 3350) on October 6, 2009, marking a significant move that intensifi...
On September 25, 2009, Janssen Biotech, Inc. received FDA approval for Ustekinumab (Stelara), a monoclonal antibody scheduled to generate substantial ...
Hospira, Inc. received approval from the FDA for its generic Heparin Sodium injection, a strategic move likely to deepen the company's share in the ac...
KVK-TECH, INC. has received FDA approval for the Abbreviated New Drug Application (ANDA091393) regarding Oxycodone Hydrochloride, a generic formulatio...
Securities and Exchange: Aurobindo Pharma Limited announced the approval of its Abbreviated New Drug Application (ANDA065442) for generic clindamycin ...
EPIC Pharma received FDA approval for Abbreviated New Drug Application ANDA090895, which positions the company to enter the generic market, potentiall...
# FDA Approves Lundbeck's SABRIL (Vigabatrin) for Oral Use Lundbeck Pharmaceuticals LLC has received FDA approval for SABRIL (vigabatrin) oral formul...
# FDA Approves Digoxin Generic from Amneal Pharmaceuticals Amneal Pharmaceuticals of New York LLC received FDA approval for its generic digoxin oral ...
# FDA Approves AMAG Pharmaceuticals' FERAHEME for Iron Deficiency Treatment AMAG Pharmaceuticals, Inc. received FDA approval for FERAHEME (ferumoxyto...
SUN PHARM INDS LTD announced its approval of the ANDA for *[Substance Name]* from the FDA on June 26, 2009, unlocking a lucrative market opportunity f...
Allergan, Inc. secured FDA approval for its intravitreal dexamethasone implant OZURDEX on June 17, a move that solidified the company's leadership pos...
Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals received FDA approval in 2009 for generic glyburide/metformin hydrochloride, expanding access to t...
Teva Pharmaceuticals USA, Inc. announced the approval of a new Andrond application for generic Mycophenolate Mofetil, a low-cost oral immune suppressa...
Accord Healthcare Inc. has announced the addition of Mycophenolate Mofetil—marketed as Myfortic—to its portfolio, providing pharmacists with a B2B500 ...
Teva Pharmaceutical announced Friday that it received FDA approval for its Abbreviated New Drug Application, referred to as M-10099, aimed at boosting...
Although the specific pharmaceutical notations for this approval are currently unavailable, the 2009-05-01 NDA021918 clearance for LAB SALVAT signals ...
Par Health USA, LLC announced the approval of its Abbreviated New Drug Application for Risperidone on April 30, 2009, which is expected to drive immed...
# FDA Approves Generic Drug Application for Sun Pharmaceutical Industries Sun Pharmaceutical Industries Inc. received FDA approval for an abbreviated...
# FDA Approves Novartis's Afinitor (Everolimus) for Oncology Treatment Novartis Pharmaceuticals Corporation received FDA approval for Afinitor (evero...